Nadine S. Jahchan, Ph.D.
Affiliations: | 2010 | Molecular & Cell Biology | University of California, Berkeley, Berkeley, CA, United States |
Area:
Signal transduction pathways mediated by receptors and the mechanisms controlling the activity of the receptor kinasesGoogle:
"Nadine Jahchan"Parents
Sign in to add mentorKunxin Luo | grad student | 2010 | UC Berkeley | |
(Role of SnoN in Normal Epithelial Function and Tumorigenesis.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Juric V, Mayes E, Binnewies M, et al. (2023) TREM1 activation of myeloid cells promotes antitumor immunity. Science Translational Medicine. 15: eadd9990 |
Binnewies M, Pollack JL, Rudolph J, et al. (2021) Targeting TREM2 on tumor-associated macrophages enhances immunotherapy. Cell Reports. 37: 109844 |
Riess JW, Jahchan NS, Das M, et al. (2020) A PHASE IIA STUDY REPOSITIONING DESIPRAMINE IN SMALL CELL LUNG CANCER AND OTHER HIGH-GRADE NEUROENDOCRINE TUMORS. Cancer Treatment and Research Communications. 23: 100174 |
Yang D, Qu F, Cai H, et al. (2019) Axon-like protrusions promote small cell lung cancer migration and metastasis. Elife. 8 |
Jahchan NS, Mujal AM, Pollack JL, et al. (2019) Tuning the Tumor Myeloid Microenvironment to Fight Cancer. Frontiers in Immunology. 10: 1611 |
Yang D, Qu F, Cai H, et al. (2019) Author response: Axon-like protrusions promote small cell lung cancer migration and metastasis Elife |
Binnewies M, Abushawish M, Lee T, et al. (2019) Abstract C104: Therapeutic targeting of TREM2+ tumor-associated macrophages as a means of overcoming checkpoint inhibitor resistance Molecular Cancer Therapeutics. 18 |
Yang D, Denny SK, Greenside PG, et al. (2018) Intertumoral Heterogeneity in SCLC Is Influenced by the Cell Type of Origin. Cancer Discovery |
Rew Y, Du X, Eksterowicz J, et al. (2018) Discovery of a Potent and Selective Steroidal Glucocorticoid Receptor Antagonist (ORIC-101). Journal of Medicinal Chemistry |
Sunshine JC, Jahchan NS, Sage J, et al. (2018) Are there multiple cells of origin of Merkel cell carcinoma? Oncogene |